
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.210 | 14.470 | 14.260 |
Shares | 99.790 | 99.790 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 27.492 | 34.495 |
Price to Book | 4.245 | 5.006 |
Price to Sales | 3.880 | 5.004 |
Price to Cash Flow | 24.774 | 23.656 |
Dividend Yield | 0.391 | 0.655 |
5 Years Earnings Growth | 20.385 | 14.104 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 79.880 | 96.226 |
Consumer Defensive | 7.170 | 7.170 |
Financial Services | 6.940 | 3.263 |
Technology | 6.000 | 6.000 |
Number of long holdings: 23
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Divi's Labs | INE361B01024 | 9.89 | 6,835.00 | -0.14% | |
Aster DM Healthcare | INE914M01019 | 9.46 | 606.90 | +1.17% | |
RPG Life Sciences Limited | INE105J01010 | 7.87 | 2,526.20 | -0.48% | |
SeQuent Scientific | INE807F01027 | 6.80 | 184.32 | -2.08% | |
Pfizer Ltd | INE182A01018 | 6.49 | 5,517.00 | +0.79% | |
Future on Lupin Ltd | - | 6.19 | - | - | |
Alivus Life Sciences | INE03Q201024 | 6.15 | 1,014.60 | -0.74% | |
Zydus Wellness | INE768C01010 | 6.00 | 2,019.10 | +0.27% | |
Aurobindo Pharma | INE406A01037 | 5.98 | 1,124.80 | -0.45% | |
HDFC Life | INE795G01014 | 5.81 | 759.00 | -1.59% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
INF966L01689 | 282.05B | 1.15 | 33.10 | 20.81 | ||
INF966L01051 | 282.05B | 0.68 | 31.64 | 19.92 | ||
Quant Mid Cap Fund Growth | 90.32B | -0.02 | 25.50 | 16.93 | ||
INF966L01887 | 90.32B | 0.54 | 27.35 | 18.22 | ||
Quant Consumption Fund Growth | 71.53B | 3.59 | 24.00 | 19.13 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review